- Reaction score
- 365
So equol and DGLA are not particularly expensive chemicals to produce right? Because obviously that would be the big concern for Fidia - and by extension, ourselves - is if the lotion can even be reasonably expected to be profitable after commercialization. I know that's why Aderans decided to pull the plug even though they likely had a fairly solid maintenance solution. Obviously this point is moot if the lotion proves to be ineffective for Androgenetic Alopecia, but even if it doesn't work that well, given the constraints they can avoid by selling it as a cosmetic, it would be pretty shocking at this point if this doesn't reach the market. The question now is when..